ENI Versalis
Produces specialized polymer materials including HDPE grades for FDM filaments and pellet printing in industrial and medical applications.
- CEO / Founder
- Adriano Alfani
- Team Size
- 1001-5000
- Stage
- Subsidiary
- Total Funding
- Publicly Traded
- Key Investors
- Eni
Technology & Products
Key Products
Wide range of products with a special focus on sustainable, consumer and high-performance products, from intermediates to polymers.
Technological Advantage
Claimed: High-density polyethylene homopolymer with medical/pharma-approved antioxidants. Verified: Used in large-scale projects like the WASP Bikechair for structural integrity.
Differentiation
Value Proposition
Provides medical/pharma-approved high-density polyethylene (HDPE) for rigid prototypes, reducing material limitations in FDM while supporting large-scale sustainable production.
How They Differentiate
Focuses on specialized HDPE grades for medical applications and large-scale industrial printing, leveraging Eni's massive chemical production infrastructure.
Market & Competition
Target Customers
Manufacturers of 3D printing filaments, medical device prototypers, and industrial designers.
Industry Verticals
Medical; Pharmaceutical; Industrial
Competitors
NOVA Chemicals, Ascend Performance Materials, CPChem
Growth & Milestones
Growth Metrics
Production 6 million tonnes, €6 billion turnover (2013 baseline)
Major Milestones
Bikechair postural sitting project with WASP; High-resolution concrete formwork research collaboration; Launch of Impressio HD 760 for medical FDM printing
Notable Customers
Kimya (Armor Group), TreeD Filaments, Forever Plast, Novamont (Matrìca JV partner).